The decline in Apellis Pharmaceuticals' stock price is a direct response to their Q1 earnings release. Typically, earnings reports can significantly impact a company's stock price in the short term, depending on whether the financial results meet, exceed, or fall short of market expectations. In this case, the negative market reaction suggests that the earnings report may have not met investor expectations, leading to a decrease in stock price.